-
421
Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations
Published 2024-12-01“…Abstract While marked differences exist between influenza virus, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is substantial overlap in the vulnerability of populations most at risk for severe disease following infection, chief among them being advanced age, multiple comorbidities, and immunocompromise. …”
Get full text
Article -
422
Investigation of the seroprevalence to equine coronavirus and SARS-CoV-2 in healthy adult horses recently imported to the United States
Published 2024-12-01“…Adult horses are susceptible to equine coronavirus (ECoV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), although, only ECoV has been linked to clinical disease. …”
Get full text
Article -
423
Accuracy of point-of-care SARS-CoV-2 detection using buccal swabs in pediatric emergency departments
Published 2024-12-01“…ABSTRACT To optimize the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected children, specimen collection and testing method are crucial considerations. …”
Get full text
Article -
424
Navigating SARS-CoV-2-related immunopathology in Crohn’s disease: from molecular mechanisms to therapeutic challenges
Published 2024-11-01“…Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) not only posed major health and economic burdens to international societies but also threatens patients with comorbidities and underlying autoimmune disorders, including Crohn’s disease (CD) patients. …”
Get full text
Article -
425
COVID-19 Pandemic and Its Impact on Perinatal Outcomes between Symptomatic and Asymptomatic Women
Published 2022-01-01“…All pregnant women with positive reverse transcriptase-polymerase chain reaction (RT-PCR) test results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were enrolled, and their perinatal outcomes were analyzed in two groups based on whether they were symptomatic or not. …”
Get full text
Article -
426
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
Published 2020-05-01“…Expert guidelines for the diagnosis and management of IR-pneumonitis include multidisciplinary input from medical oncology, pulmonary medicine, infectious disease, and radiology specialists. Severe acute respiratory syndrome coronavirus 2 is a recently recognized respiratory virus that is responsible for causing the COVID-19 global pandemic. …”
Get full text
Article -
427
Aerosol Filtration Testing of Fabrics for Development of Reusable Face Masks
Published 2021-05-01“…Abstract The ongoing outbreak of coronavirus disease of 2019 (COVID-19), triggered by the rapid community spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought forward the need for speedy testing and manufacturing of respiratory face masks for global use. …”
Get full text
Article -
428
Machine Learning Early Detection of SARS‐CoV‐2 High‐Risk Variants
Published 2024-12-01“…Abstract The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has evolved many high‐risk variants, resulting in repeated COVID‐19 waves over the past years. …”
Get full text
Article -
429
Incorporation of Silver into Sulfate Groups Enhances Antimicrobial and Antiviral Effects of Fucoidan
Published 2024-10-01“…Infections of human cells with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus were more effectively inhibited by lower concentrations of Ag-Fuc compared with fucoidan. …”
Get full text
Article -
430
Retrospective study of factors associated with the clinical severity of covid-19 in older adults in Minas Gerais: structural equation modeling
Published 2024-12-01“…Data were collected through the Individual Registration Form – Hospitalized Cases of Severe Acute Respiratory Syndrome from January 28, 2020, to January 27, 2022. …”
Get full text
Article -
431
Assessment of the Peripheral and Central Auditory System in Infants Whose Mothers Tested Positive for COVID-19 During Pregnancy
Published 2024-12-01“…Introduction: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a new member of the coronavirus family. …”
Get full text
Article -
432
Emergency medicine resident productivity during the SARS-CoV-2 disease 2019 (COVID-19) pandemic
Published 2024-09-01“…Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) pandemic disrupted medical education in many care settings, including the Emergency Department (ED). …”
Get full text
Article -
433
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients
Published 2020-01-01“…A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing lethal acute respiratory disease emerged in December 2019. …”
Get full text
Article -
434
The Impact of <i>Acinetobacter baumannii</i> Infections in COVID-19 Patients Admitted in Hospital Intensive Care Units
Published 2023-11-01“…Since the end of 2019, the Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, affecting people worldwide. …”
Get full text
Article -
435
New-onset Diabetes Mellitus among adults as sequelae of COVID-19 in selected tertiary care hospital, Puducherry – A cohort study
Published 2025-01-01“…Background: Diabetes Mellitus is one of the most common comorbidities in patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, data on the incidence of Diabetes Mellitus among adults as post-COVID sequelae has been limited, and this study aims to determine the incidence and the associated factors of Diabetes Mellitus among adults who had COVID-19 infection. …”
Get full text
Article -
436
Trends in Bacterial and Candida Infections Before and Throughout the COVID-19 Pandemic
Published 2024-11-01“…The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virus, resulted in significant global health consequences. …”
Get full text
Article -
437
Dysbiosis of gut microbiota in patients with severe COVID‐19
Published 2024-01-01“…Abstract Aim Altered gut microbiota has been proposed as one of the causes of exacerbation of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2/COVID‐19) from the perspective of the gut–lung axis. …”
Get full text
Article -
438
Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics
Published 2021-01-01“…Despite the worldwide spread of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), information about the epidemiological and clinical patterns of this infection is still largely unknown in children. …”
Get full text
Article -
439
Seroprevalence of IgM/IgG and Neutralizing Antibodies against SARS-CoV-2 in Unvaccinated Young Adults from Mexico Who Reported Not Having Had a Previous COVID-19 Infection
Published 2024-01-01“…Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19). …”
Get full text
Article -
440
Druggability and molecular docking of essential secondary metabolites from Azadirachta indica leaf against angiotensin converting enzyme-2: Covid-19 in focus
Published 2025-02-01“… Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious and virulent coronavirus that arose in late 2019 and poses great risk to public health and safety. …”
Get full text
Article